Nutrient-Laden Nanoparticles for Pathogen Eradication

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current antimicrobial strategies face limitations due to the development of resistance, side effects, and incomplete eradication of pathogens, particularly in addressing the diversity and adaptive mechanisms of bacteria, fungi, viruses, protozoa, and parasites.

Innovation Solution

A dual-action formulation combining a biocidal agent with a nutritive component, designed to stimulate chemotaxis in pathogens, attracting them to ingest a toxin encapsulated in a nutritive matrix, utilizing Layer-by-Layer (LbL) assembly to construct nanoparticles that mimic nutrient uptake stimulants.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional antimicrobial strategies are used, then pathogens can be targeted, but resistance develops and eradication is incomplete

Engineering Contradiction:
Improvepathogen eradication effectivenessVSAvoidpathogen resistance development
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The nanoparticle is segmented into distinct functional layers: an outer nutritive layer that attracts pathogens and an inner biocidal layer that eradicates them. This segmentation allows the pathogen to be targeted by multiple mechanisms simultaneously (chemotaxis attraction followed by toxin exposure), preventing resistance development while maintaining high eradication effectiveness.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention uses composite nanoparticle structures combining organic nutritive materials (sugars, amino acids, lipids) with inorganic or synthetic biocidal agents (metal oxides, antibiotics, photosensitizers). This composite approach creates a dual-functional system that both attracts and kills pathogens, addressing both reliability and adaptability concerns through multifaceted action.

Inventive Principle:
Principle #40Composite materials

2Productivity

If biocidal agents are delivered directly, then pathogen killing is achieved, but side effects occur and resistance increases

Engineering Contradiction:
Improvebiocidal agent delivery efficiencyVSAvoidside effects and resistance
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The nanoparticle structure serves as an intermediary delivery vehicle that carries the biocidal agent to the pathogen through a nutritive matrix. The pathogen is attracted to the nutrient-laden nanoparticle and ingests it, allowing the biocidal agent to be delivered directly into the pathogen's interior. This intermediary approach increases delivery efficiency while minimizing side effects by localizing the biocidal action exclusively within the pathogen.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The pathogen's own nutrient-uptake mechanisms are exploited to deliver the biocidal agent. The pathogen actively seeks out and ingests the nanoparticle thinking it is a nutrient source, thereby self-administering the toxin. This self-service mechanism maximizes delivery efficiency while ensuring the biocidal agent is concentrated precisely where needed, reducing systemic side effects and resistance development.

Inventive Principle:
Principle #25Self-service

3Manufacturing precision

If nanoparticle size is reduced for better pathogen targeting, then delivery precision improves, but manufacturing complexity increases

Engineering Contradiction:
Improvenanoparticle size controlVSAvoidLayer-by-Layer assembly process
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The Layer-by-Layer assembly process uses periodic deposition and rinsing cycles to build up the nanoparticle structure. Each cycle deposits a thin layer of material, rinses excess away, and prepares the surface for the next layer. This periodic action allows precise control over nanoparticle size and composition through simple, repeatable steps, reducing manufacturing complexity despite the need for precise size control.

Inventive Principle:
Principle #19Periodic action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances the delivery and effectiveness of biocidal agents by leveraging innate nutrient-seeking behaviors of pathogens, ensuring precise targeting and direct exposure to the active agent, thereby optimizing efficacy and reducing resistance and side effects.

Implementation Method 1

The nutritive component is formulated to stimulate chemotaxis in pathogens, such as bacteria, fungi, and viruses, attracting them into proximity to facilitate ingestion of a toxin encapsulated in the nutritive matrix

Methodology Applied
Scientific EffectChemotaxis:

Implementation Method 2

utilizing Layer-by-Layer (LbL) assembly to construct nanoparticles that mimic nutrient uptake stimulants

Methodology Applied
Scientific EffectLayer-by-Layer assembly:

Data Source

PatentUS12225906B1Pathogenic affinity pathway of infectious or parasitic organisms for nanogram and picogram dosimetry prophylaxis or cure
Publication Date: 2025.02.18 BRADY TERRY EARL
  • US12225906B1 patent drawing

AI summary

The sustenance of life is driven by recognition of and access to energy sources. This process has remained unchanged over billions of years, guiding cellular nutrition through molecular recognition, akin to the food pyramid. At the atomic or nanoscale, chemotaxis enables organisms to identify ingestible matter and is driven by their need for fuel, rather than from the sustenance itself. Chemotaxis, one of nature's most potent yet invisible organic forces, operates independently of molecular charge dynamics to locate and identify microscopic sustenance. Infectious organisms, such as pathogenic microbes and parasites, depend on chemotactic pathways to locate nutrition across all scales. This invention leverages this phenomenon by “baiting” these pathways with nutritive matter that encapsulates biocidal agents that are harmless to humans but lethal to infectious organisms once ingested. These nutritive biocidal agents could be employed as topical, oral, injectable, or aerosolized formulations, as well as hydrogel or slow-release implants.